Clinical Trial Update: The Japan-Combined Treatment With Olmesartan and a Calcium Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study (J-CORE) [Phase 4]

View source ↗

Summary

Phase 4 randomized study in Japan comparing olmesartan plus a calcium channel blocker versus olmesartan plus a diuretic for hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Calcium channel blocker (calcium channel blocker)
• Diuretic (diuretic)
• Olmesartan (olmesartan)

Snippet

Sponsor: Jichi Medical University | Conditions: Hypertension | Phase 4 | Status: COMPLETED